COR Therapeutics Hammered After Hours Following Profit Warning

COR Therapeutics ( CORR) lowered its guidance for the first quarter and 2001, saying that wholesaler inventory levels have fallen sharply from the end of last year.

The pharmaceutical products company now expects sales of $37 million to $39 million for the first quarter and $245 million to $260 million for 2001. The company previously expected sales of $250 million to $270 million for the year.

Shares of COR lost $1.75 to $31.75 in regular-session Nasdaq trading, but fell to $25.88 in after-hours Instinet activity. In late Island action, the stock traded at $26.50.

COR also projected a first-quarter loss of 5 cents to 7 cents a share, reversing the consensus earnings projection of 3 cents a share, according to First Call/Thomson Financial. For the year, the company expects earnings of 35 cents to 37 cents, below Wall Street's estimate of 40 cents.

The company, which is based in South San Francisco, Calif., lost 19 cents in the year-ago first quarter and 31 cents for 2000.

More from Investing

Marc Chaikin's Technical Tools: Cramer's Off the Charts

Marc Chaikin's Technical Tools: Cramer's Off the Charts

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

Carnival CEO Arnold Donald: China Will Become the Largest Cruise Market

In Pugnacious Twitter Rant, Musk Proposes Website for Users to Rate the Media

In Pugnacious Twitter Rant, Musk Proposes Website for Users to Rate the Media

One-on-One With Carnival Corporation CEO Arnold Donald (Watch)

One-on-One With Carnival Corporation CEO Arnold Donald (Watch)

Bitcoin Today: Prices Plummet Below $8,000 in Market Downturn

Bitcoin Today: Prices Plummet Below $8,000 in Market Downturn